P-200NB-250

Hazard statements (CLP)

H302, H335

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

2.2 Label elements

0 2 HEALTH 2 0 FLAMMABILITY - continued P284 - Respiratory Protection: If workplace exposure limit(s) of product or any component is exceeded (see TLV/PEL), or a risk assessment shows air-purifying respirators are appropriate, use of a NIOSH/MSHA approved air supplied respirator is advised. Use a full-face respirator with multi-purpose combination (US) or type ABEK (EN14387) respirator cartridges in absence of proper environmental control. Always use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Engineering and/or administrative controls should be implemented to reduce exposure. P338 - Eye contact: Immediately flush with plenty of water. After initial flushing, remove and contact lenses and continue flushing for at least 15 minutes. Assure adequate flushing by separating the eyelids with fingers. P360 - Skin contact: Immediately wash skin with soap and plenty of water. Remove contaminated clothing. Get medical attention if symptoms occur. Wash clothing before reuse.

Signal word

0

Hazard statements

H302 - Harmful if swallowed. (Acute toxicity, oral, category 4) H335 - May be irritating to mucous membrane and upper respiratory system. (Specific target organ toxicity, single exposure; Respiratory tract irritation, category 3) Precautionary Codes: P202 - This product should only by used by persons trained in the safe handling of hazardous chemicals. P233 - Store in a tightly closed container. (P404) P235 - Store in a cool dry place. P262 - Do not get in eyes, on skin or clothing. P264 - Wash thoroughly after handling. Do not take internally. Eye wash and safety equipment should be readily available. - continued

2.3 Other hazards

2.2.1 - Symptom of Exposure Health/Environment Cholinesterase inhibitor. Can cause heavy salivation and secretion in the lungs, lachrymation, blurred vision, involuntary defacation, diarrhea, tremor, ataxia, sweating, hypothermia, lowered heart rate and/or a fall in blood pressure. Lachrymator - causes tearing, blurred vision and pain in the eyes. Neurotoxic effects including nausea, vomiting, diarrhea lethargy, convulsions, headache, dizziness, drowsiness, incoordination, slowed reaction time, slurred speech, giddiness and unconsciousness.

Potential health effects

May be irritating to eyes. May be irritating to skin. May be harmful if absorbed through the skin. (Acute toxicity, dermal, category 5) May be irritating to mucous membrane and upper respiratory system. (Specific target organ toxicity, single exposure; Respiratory tract irritation, category 3) May be harmful if inhaled. (Acute toxicity, inhalation, category 5) Harmful if swallowed. (Acute toxicity, oral, category 4) 2.2.3 - Routes of Entry Inhalation, ingestion or skin contact. 2.2.4 - Carcinogenicity This product is or contains a component that is not listed (ACGIH, IARC, NTP, OSHA) as a cancer causing agent.